Actuate Therapeutics

ACTUNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$26.438 M

$1.11 -10.16%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$22.2M

Loss-making

Shares outstanding

23,709,943

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#380BioXcel TherapeuticsBTAI$27.8M
#381Abvc BiopharmaABVC$27.1M
#382Actuate TherapeuticsACTU$26.4M
#383Aytu BiopharmaAYTU$25.3M
#384Actinium PharmaceuticalsATNM$25.0M

Where these numbers come from

Share counts and financials for Actuate Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.